Biocompatibility

Show results for

Unknown (7895)
Genomics (96)
Transcriptomics (56)
Proteomics (49)
Metabolomics (2)
Other (1)

Organisms

Mus musculus (30)
Homo sapiens (28)
Aerococcus urinae NBRC 15544 = CCUG 36881 (27)
Allexis (27)
Canis lupus familiaris (27)
Carya cathayensis (27)
Clostridioides difficile 630 (27)
Cyanophora paradoxa (27)
Ensifer adhaerens (27)
Enterococcus faecalis (27)
Globicatella sanguinis (27)
Histomonas meleagridis (27)
Human immunodeficiency virus 1 (27)
Listeria monocytogenes (27)
Lotus japonicus (27)
Marchantia polymorpha (27)
Methylohalobius crimeensis 10Ki (27)
Mus musculus (27)
Mycobacterium tuberculosis (27)
Ophrys garganica (27)
Ophrys sphegodes (27)
Physcomitrium patens (27)
Rattus norvegicus (7)
Escherichia coli (3)
Oryctolagus cuniculus (2)
Sus scrofa (1)
Escherichia coli Nissle 1917 (1)
Caenorhabditis elegans (1)
Saccharomyces cerevisiae (1)
Bacteria (1)

Organisms

Mus musculus (20)
Homo sapiens (18)
Rattus norvegicus (7)
Acidithiobacillus ferrooxidans (1)
Staphylococcus saprophyticus (1)
Escherichia coli Nissle 1917 (1)
Oryctolagus cuniculus (1)
rat gut metagenome (1)
Caenorhabditis elegans (1)
Escherichia coli (1)

Repository

ENA (95)
geo (48)
pride (27)
iProX (12)
biostudies-arrayexpress (10)
MassIVE (7)
jPOST (3)
GNPS (1)
MetaboLights (1)

Tissue

Cell culture (8)
Blood cell (3)
Blood plasma (3)
Blood (2)
Fibroblast (2)
Macrophage (2)
Skin (2)
Arterial system (1)
Blood platelet (1)
Bronchoalveolar lavage (1)
CACO-2 cell (1)
Callus (1)
Epithelial cell (1)
Erythrocyte (1)
Heart (1)
Hepatocyte (1)
Intestine (1)
JURKAT cell (1)
Monocyte (1)
Osteoblast (1)
Placenta (1)
Stem cell (1)
T-lymphoblastic leukemia cell line (1)
Tibia (1)

Disease

Disease free (2)
Wounds and Injuries (2)
Charlevoix-Saguenay spastic ataxia (1)

Technology Type

Mass Spectrometry (27)
Shotgun proteomics (19)
Bottom-up proteomics (5)
Affinity purification coupled with mass spectrometry proteomics (3)
Data-dependent acquisition (2)
NMR spectroscopy (1)
Data-independent acquisition (1)
Gel-based experiment (1)

Instrument Platform

Orbitrap Fusion (4)
Q Exactive (2)
10x Genomics Chromium Controller, PCR thermocycler, Agilent 2100 Bioanalyzer with High Sensitivity DNA chip (for quality control) (1)
Water bath (for enzymatic dissociation), cell strainer (70-μm), benchtop centrifuge, automated cell counter/hemocytometer, biological safety cabinet (1)
Sterile surgical instrument set (scalpels, tissue forceps, dissection scissors), animal operating table, biological safety cabinet (1)
Illumina HiSeq 2500 (1)
Illumina NovaSeq 6000 (1)
Q Exactive Plus (1)
Bruker Impact II (1)
Nuclear Magnetic Resonance (NMR) (1)

Publication Date

2025 (17)
2026 (17)
2023 (13)
2022 (12)
2012 (10)
2024 (8)
2021 (8)
2018 (5)
2020 (5)
2017 (4)
2015 (2)
2014 (2)
2019 (1)
2010 (1)
2004 (1)

CHEBI ID

CHEBI:18132 (1)
CHEBI:15846 (1)
CHEBI:16870 (1)
CHEBI:16977 (1)
CHEBI:15741 (1)
CHEBI:18019 (1)
CHEBI:15891 (1)
CHEBI:17053 (1)
CHEBI:16027 (1)
CHEBI:16761 (1)
CHEBI:78320 (1)
CHEBI:16919 (1)
CHEBI:16414 (1)
CHEBI:17191 (1)
CHEBI:15354 (1)
CHEBI:15603 (1)
CHEBI:17895 (1)
CHEBI:17295 (1)
CHEBI:17368 (1)

Metabolite Name

L-leucine (1)
Taurine (1)
Phosphocholine (1)
NAD+ (1)
Hypoxanthine (1)
AMP (1)
Choline (1)
Creatine (1)
Succinate (1)
Lactate (1)
L-alanine (1)
L-aspartic acid (1)
ADP (1)
L-lysine (1)
Glycerophosphocholine (1)
L-Valine (1)
L-Isoleucine (1)
L-Tyrosine (1)
L-Phenylalanine (1)

First Public Date

2025 (29)
2026 (21)
2024 (11)
2014 (8)
2022 (7)
2023 (6)
2019 (4)
2020 (3)
2021 (2)
2017 (2)
2015 (2)

Classification

bacteria (2)

Study type

Transcription profiling by array (7)
RNA-seq of coding RNA (2)
RNA-seq of coding RNA from single cells (1)

Release Date

2025 (1439)
2022 (1137)
2023 (1052)
2024 (942)
2021 (818)
2020 (560)
2019 (436)
2018 (408)
2017 (278)
2026 (240)
2016 (170)
2015 (121)
2014 (107)
2013 (60)
2012 (47)
2011 (31)
2010 (27)
2009 (19)
2008 (6)
2007 (5)
2006 (1)
2001 (1)

Lab affiliation

1.Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China 2.State Key Laboratory of Natural and Biomimetic Drugs, Beijing 100191, China 3.Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China (1)
1.Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China 2.State Key Laboratory of Natural and Biomimetic Drugs, Beijing 100191, China Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China (1)
Associate Professor (1)
Cancer Science Institute of Singapore (CSI), National University of Singapore (NUS) (1)
Center for Biodesign and Diagnostics (1)
Department of Medical Protein Research, VIB & Department of Biochemistry, UGent, Ghent, Belgium (1)
Department of Medicine and General Service of Cytometry, Cancer Research Centre-IBMCC, IBSAL. University of Salamanca-CSIC, Campus Miguel de Unamuno s/n, 37007 Salamanca, Spain (1)
Department of Ophthalmology University Medical Center Mainz Germany (1)
Erytech 60, avenue Rockefeller • Bâtiment Adénine • 69008 Lyon • France (1)
Genecology Research Centre, University of the Sunshine Coast (1)
Head of Research Department of Obstetrics University Hospital Zurich Schmelzbergstrasse 12 PATH G48 / PF 125 CH-8091 Zürich Switzerland (1)
Head of the Laboratory for Vascular Biology, Department of Experimental Medicine,Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russian Federation (1)
IRCCS G. Gaslini (1)
IRCCS Istituto Giannina Gaslini (1)
Institute of Biochemistry II University Hospital Frankfurt Goethe University Germany (1)
Laboratory of Cardiovascular Medicine, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy (1)
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125 Berlin, Germany Department of Chemistry, Humboldt Universität zu Berlin, Brook-Taylor-Straße 2, 12489 Berlin, Germany (1)
Nanobio Measurement Group, Division of Biomedical Metrology, Korea Research Institute of Standard and Science, 267 Gajeong-ro, Yuseong-gu, Daejeon 34113, Republic of Korea (1)
Professor Department of Biochemistry and Molecular Biology University of Southern Denmark (1)
Professor i molekylærbiologi og faglig leder av PROMEC Institutt for klinisk og molekylær medisin Fakultet for medisin og helsevitenskap geir.slupphaug@ntnu.no 72573076 91825455 Laboratoriesenteret, 231.05.034, Øya, Erling Skjalgssons g 1 (1)
Proteomics Department, Institute of Cellular Biology and Pathology "N. Simionescu", Romania (1)
Proteomics Service CIC bioGUNE Bizkaia Tech. Park Build. 800 48160 Derio (Spain) (1)
School of Biomedical Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, 2052, Australia (1)
Staff Scientist Biological Systems & Engineering Division Lawrence Berkeley National Laboratory Berkeley CA 94720 (1)
State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. (1)
TIGEM (1)
c. University of Tübingen, Department of Immunology, Institute of Cell Biology, Auf der Morgenstelle 15, Tübingen 72076, Germany (1)

Previous page
1 / 810
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 810
Next page

Sort by:

Relevance

Page size

biocompatibility results for endovascular medical device

PRJNA1377419 | ENA

Improved Biocompatibility of Amino-functionalized Graphene Oxide in Caenorhabditis elegans

PRJNA542590 | ENA

biocompatibility results for endovascular medical device

In this project, we developed an endovascular medical device. To evaluate its biocompatibility, the device (experimental) or a clinical medical device (control) was co-cultured with human immune cells. We further conducted single-cell RNA sequencing to examine potential immunogenic responses at the ...

ORGANISM(S): Homo sapiens

2025-12-15 | GSE312793 | GEO

In vitro biocompatibility of ZrO2 vs Y-TZP alloys on Saos-2 cells: influence of composition and surface topography

This study assess the biocompatibility of ZrO2 vs Y-TZP alloys on Saos-2 cells, through the combination of conventional toxicological assay, morphological observations and transcriptomic analysis performed on Saos-2 cells. The biocompatibility of ZrO2 alloys was evaluated in comparison with Y-TZP al...

ORGANISM(S): Homo sapiens

2022-07-13 | GSE203572 | GEO

In vitro biocompatibility of ZrO2 vs Y-TZP alloys on Saos-2 cells: influence of composition and surface topography

PRJNA841478 | ENA

Improved Biocompatibility of Amino-functionalized Graphene Oxide in Caenorhabditis elegans

Graphene oxide (GO) holds high promise for diagnostic and therapeutic applications in nanomedicine but reportedly displays immunotoxicity, underlining the need for developing functionalized GO with improved biocompatibility. Here, we study the adverse effects of GO and amino-functionalized GO (GONH2...

ORGANISM(S): Caenorhabditis elegans

2022-05-10 | GSE131070 | GEO

In vitro biocompatibility of Ti-Cp vs Ti-26Nb alloys on Saos-2 and THP-1 cells

PRJNA813298 | ENA

Biocompatibility and Discovery of the Potential Applications of Magnetite (Fe3O4) Nanoparticles

A Transcriptomics Approach to Study the Biocompatibility and Finding out the Potential Applications of Magnetite (Fe3O4) Nanoparticles Here in this study, we examine the molecular effects of uptake of Fe3O4 nanoparticles using a whole genome microarray study in human epithelial cancer cell line. 38 ...

ORGANISM(S): Homo sapiens

2010-03-13 | GSE15248 | GEO

In vitro biocompatibility of Ti-Cp vs Ti-26Nb alloys on Saos-2 and THP-1 cells

This study assess the biocompatibility of Ti-26Nb compared to Ti-Cp, a reference in implantology, through the combination of conventional toxicological assay, morphological observations and transcriptomic analysis performed on two different cells line : Saos-2 and THP-1. The biocompatibility of Ti-C...

ORGANISM(S): Homo sapiens

2022-08-31 | GSE197987 | GEO

Biocompatibility Evolves: Phenomenology to Toxicology to Regeneration.

Not available

S-EPMC8221530 | biostudies-literature

Previous page
1 / 810
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 810
Next page

Sort by:

Relevance

Page size

8099 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets